Login / Signup

MEX3D is an oncogenic driver in prostate cancer.

Longjiang ShaoJianghua WangOmer KaratasMichael M Ittmann
Published in: The Prostate (2021)
Loss of PTEN and expression of the TE fusion gene in prostate cancer strongly upregulates expression of MEX3D and its target TCF3 and promotes transformation associated phenotypes via this pathway.
Keyphrases
  • prostate cancer
  • poor prognosis
  • radical prostatectomy
  • binding protein
  • cell proliferation
  • copy number
  • long non coding rna
  • genome wide
  • gene expression
  • dna methylation
  • pi k akt